Medical care for patients with pulmonary hypertension (PH) was affected during the first wave of the COVID-19 pandemic,…
Articles by Patricia Inácio, PhD
More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less…
Pulmonary hypertension (PH) increases the likelihood of a prolonged hospitalization following an acute ischemic stroke, or a stroke due…
The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a…
Matt J. Granato is the newly named president and CEO of the Pulmonary Hypertension Association (PHA), the nonprofit group…
Treatment with bosentan may lower the risk of developing pulmonary hypertension (PH) and help stabilize lung function in…
Treatment with Acceleron Pharma’s sotatercept leads to substantial improvements in cardiac parameters, as well as exercise tolerance and capacity,…
A new virtual tool, called VEST, is aiding clinicians in remotely diagnosing people with Group 1 pulmonary hypertension (PH)…
People with intermediate-risk pulmonary arterial hypertension (PAH) who failed to respond adequately to phosphodiesterase-5 inhibitors (PDE5i) show significant benefits…
The five-year survival rate is markedly reduced among adults with pulmonary arterial hypertension (PAH) due to congenital heart disease…
Preterm babies with the lung condition bronchopulmonary dysplasia (BPD) — a risk factor for the development of pulmonary…
Anodal block, a technique based on electrical nerve stimulation, allows for the selective activation of fibers in the vagus nerve,…